胰腺或胰岛移植后1型糖尿病复发的预测

doi:10.3877/cma.j.issn.2095-1221.2020.06.008

胰腺或胰岛移植后的1型糖尿病复发（T1DR）是影响远期移植物功能的关键因素之一。由T1DR导致的移植物功能丧失约占7﹪，与慢性同种排斥反应的发生率相当。然而，由于T1DR引起的复发性高血糖缺乏特异性，导致一直以来临床上T1DR发生被严重低估。移植物组织活检提示特异性靶向β细胞的炎性T细胞浸润是诊断T1DR的"金标准"。但是，作为一种有创性操作，组织活检不作为常规筛查T1DR方法。研究显示监测移植受者的胰岛自身抗体和抗原特异性T细胞对T1DR具有预测价值。本文就胰岛自身抗体和抗原特异性T细胞对预测T1DR作一综述。

关键词: 1型糖尿病, 胰腺移植, 胰岛移植, 胰岛自身抗体, 抗原特异性T细胞, 复发

Type 1 diabetes recurrence (T1DR) after pancreas or islet transplantation is one of the key factors affecting long-term graft function. The loss of graft function caused by T1DR accounts for about 7﹪, which is comparable to the incidence of chronic allograft reaction. However, due to the lack of specificity of recurrent hyperglycemia caused by T1DR, the occurrence of T1DR has been seriously underestimated clinically. A biopsy showing an inflammatory T-cell infiltrate, specifically targeting the β cells is the "gold standard" for the diagnosis of T1DR. As an invasive procedure, biopsy is not used as a generally screening method. Studies have shown that monitoring islet autoantibodies and antigen-specific T cells of transplant recipients has a predictive value for T1DR. This article reviews the prediction of T1DR by islet autoantibodies and antigen-specific T cells.

Key words: Type 1 diabetes, Pancreas transplantation, Islet transplantation, Islet autoantibody, Antigen-specific T cell, Recurrence

1	DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes[J]. Lancet, 2018, 391(10138):2449-2462.
2	刘颖, 肖平, 陈焕伟. 胰岛移植治疗1型糖尿病的现状和未来[J]. 器官移植, 2019, 10(1):91-93.
3	Vantyghem MC, Chetboun M, Gmyr V, et al. Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study[J]. Diabetes Care, 2019, 42(11): 2042-2049.
4	Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010[J]. Diabetes Care, 2012, 35(7): 1436-1445.
5	Lindahl JP, Reinholt FP, Eide IA, et al. In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone[J]. Diabetologia, 2014, 57(11):2357-2365.
6	Sánchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs[J]. Gastroenterology, 2011, 140(1):51-64.
7	Sutherland DE, Sibley R, Xu XZ, et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of typeⅠdiabetes[J]. Trans Assoc Am Physicians, 1984, 97:80-87.
8	Sibley RK, Sutherland DE, Goetz F, et al. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases[J]. Lab Invest, 1985, 53(2):132-144.
9	Vendrame F, Hopfner YY, Diamantopoulos S, et al. Risk factors for type 1 diabetes recurrence in immunosuppressed recipients of simultaneous pancreas-kidney transplants[J]. Am J Transplant, 2016, 16(1):235-245.
10	Viglietta V, Kent SC, Orban T, et al. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes[J]. J Clin Invest, 2002, 109(7):895-903.
11	Danke NA, Yang J, Greenbaum C, et al. Comparative study of GAD65-specific CD4⁺ T cells in healthy and type 1 diabetic subjects[J]. J Autoimmun, 2005, 25(4):303-311.
12	Spanier JA, Sahli NL, Wilson JC, et al. Increased effector memory insulin-specific CD4⁺ T cells correlate with insulin autoantibodies in patients with recent-onset type 1 diabetes[J]. Diabetes, 2017, 66(12): 3051-3060.
13	Monti P, Scirpoli M, Rigamonti A, et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes[J]. J Immunol, 2007, 179(9):5785-5792.
14	Monti P, Piemonti L. Homeostatic T cell proliferation after islet transplantation[J]. Clin Dev Immunol, 2013, 2013:217934.
15	Abreu JR, Roep BO. Immune monitoring of islet and pancreas transplant recipients[J]. Curr Diab Rep, 2013, 13(5):704-712.
16	Monti P, Vignali D, Piemonti L. Monitoring inflammation, humoral and cell-mediated immunity in pancreas and islet transplants[J]. Curr Diabetes Rev, 2015, 11(3):135-143.
17	Martins LS. Autoimmune diabetes recurrence should be routinely monitored after pancreas transplantation[J]. World J Transplant, 2014, 4(3):183-187.
18	Korutla L, Rickels MR, Hu RW, et al. Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation[J]. Am J Transplant, 2019, 19(6):1852-1858.
19	Toso C, Isse K, Demetris AJ, et al. Histologic graft assessment after clinical islet transplantation[J]. Transplantation, 2009, 88(11):1286-1293.
20	Rickels MR, Stock PG, de Koning EJP, et al. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop[J]. Transplantation, 2018, 102(9):1479-1486.
21	Wenzlau JM, Hutton JC. Novel diabetes autoantibodies and prediction of type 1 diabetes[J]. Curr Diab Rep, 2013, 13(5):608-615.
22	Braghi S, Bonifacio E, Secchi A, et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes[J]. Diabetes, 2000, 49(2):218-224.
23	Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation[J]. PLoS One, 2008, 3(6):e2435.
24	Martins LS, Henriques AC, Fonseca IM, et al. Pancreatic autoantibodies after pancreas-kidney transplantation-do they matter?[J]. Clin Transplant, 2014, 28(4):462-469.
25	Occhipinti M, Lampasona V, Vistoli F, et al. Zinc transporter 8 autoantibodies increase the predictive value of islet autoantibodies for function loss of technically successful solitary pancreas transplant[J]. Transplantation, 2011, 92(6):674-677.
26	Piemonti L, Everly MJ, Maffi P, et al. Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes[J]. Diabetes, 2013, 62(5):1656-1664.
27	Hilbrands R, Huurman VA, Gillard P, et al. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients[J]. Diabetes, 2009, 58(10):2267-2276.
28	Bosi E, Braghi S, Maffi P, et al. Autoantibody response to islet transplantation in type 1 diabetes[J]. Diabetes, 2001, 50(11):2464-2471.
29	Argente-Pla M, Martínez-Millana A, Del Olmo-García MI, et al. Autoimmune diabetes recurrence after pancreas transplantation: diagnosis, management, and literature review[J]. Ann Transplant, 2019, 24:608-616.
30	Pestana N, Malheiro J, Silva F, et al. Impact of pancreatic autoantibodies in pancreas graft survival after pancreas-kidney transplantation[J]. Transplant Proc, 2020, 52(5):1370-1375.
31	Rodelo-Haad C, Agüera ML, Carmona A, et al. Pancreatic autoantibodies and CD14⁺ CD16⁺ monocytes subset are associated with the impairment of β-cell function after simultaneous pancreas-kidney transplantation[J]. PLoS One, 2019, 14(2):e0212547.
32	Rodelo-Haad C, Aguera ML, Martinez-Vaquera S, et al. Tyrosine-phosphatase and glutamate-decarboxylase antibodies after simultaneous pancreas kidney transplantation: do they have an impact on pancreas graft survival?[J]. Transplant Proc, 2015, 47(1):107-111.
33	Vendrame F, Pileggi A, Laughlin E, et al. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells[J]. Diabetes, 2010, 59(4):947-957.
34	Ahmed S, Cerosaletti K, James E, et al. Standardizing T-cell biomarkers in type 1 diabetes: challenges and recent advances[J]. Diabetes, 2019, 68(7):1366-1379.
35	Roep BO, Stobbe I, Duinkerken G, et al. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients[J]. 1999, 48(3):484-490.
36	Laughlin E, Burke G, Pugliese A, et al. Recurrence of autoreactive antigen-specific CD4⁺ T cells in autoimmune diabetes after pancreas transplantation[J]. Clin Immunol, 2008, 128(1):23-30.
37	Pinkse GG, Tysma OH, Bergen CA, et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes[J]. Proc Natl Acad Sci U S A, 2005, 102(51):18425-18430.
38	Unger WW, Velthuis J, Abreu JR, et al. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers[J]. J Autoimmun, 2011, 37(3):151-159.
39	Hadrup SR, Bakker AH, Shu CJ, et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers[J]. Nat Methods, 2009, 6(7):520-526.
40	Velthuis JH, Unger WW, Abreu JR, et al. Simultaneous detection of circulating autoreactive CD8⁺ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers[J]. Diabetes, 2010, 59(7):1721-1730.
41	Monti P, Scirpoli M, Maffi P, et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells[J]. J Clin Invest, 2008, 118(5):1806-1814.

[1]	叶艳娜, 叶瑞婷, 陈艳玲, 彭雯, 刘乐, 肖文秋, 黄辉, 李明深, 钟慕仪, 叶娴. 基于影像学表现和临床病理特征预测良性与交界性乳腺叶状肿瘤复发的列线图模型[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 229-237.
[2]	崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[3]	陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[4]	阿冲罗布, 陈颖, 谢德坤. 腹腔镜外囊完整剥离术治疗肝包虫病效果及对患者肝功能、预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 666-669.
[5]	郑泽坤, 刘卓恒, 邹浩, 胡会元, 李妲, 吴巍. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 588-590.
[6]	中国器官移植发展基金会器官移植受者健康管理专家委员会, 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 国家肝脏移植质控中心. 肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(04): 193-204.
[7]	罗辉, 熊珍珍, 黄令杰, 林山, 李金雨. 盆腔淋巴结大小对膀胱癌复发的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 495-499.
[8]	邢晓伟, 刘雨辰, 赵冰, 王明刚. 基于术前腹部CT的卷积神经网络对腹壁切口疝术后复发预测价值[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 677-681.
[9]	姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗：10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[10]	蒋正东, 李徐奇, 王曙逢, 魏光兵. 复发性腹股沟疝的腹腔镜手术策略及疗效观察[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 539-543.
[11]	张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[12]	叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[13]	王晓东, 汪恺, 葛昭, 丁忠祥, 徐骁. 计算机视觉技术在肝癌肝移植疗效提升中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 361-366.
[14]	张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[15]	符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Prediction of type 1 diabetes recurrence after pancreas or islet transplantation

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Prediction of type 1 diabetes recurrence after pancreas or islet transplantation